Dihydroergocristine mesylate

CAS: 24730-10-7

Ref. 3D-FD39334

Produktinformation

• Name: Dihydroergocristine mesylate
• Synonyme: (5'Alpha,10Alpha)-5'-Benzyl-12'-Hydroxy-3',6',18-Trioxo-2'-(Propan-2-Yl)-9,10-Dihydroergotaman Methanesulfonate (1:1), 5'alpha-Benzyl-9,10alpha-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate, 9,10-Dihydroergocristine methanesulfonate, Dihydroergocristine methanesulfonate, Dihydroergocristinmesilat, Dihydroergocristinmesilat [German], Ergocristine, 9,10-dihydro-, monomethanesulfonate (salt), Ergocristine, dihydro-, methanesulfonate, Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha,10alpha)-, monomethanesulfonate (salt), Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-(phenylmethyl)-, (5′α,10α)-, methanesulfonate (1:1), Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-(phenylmethyl)-, (5′α,10α)-, monomethanesulfonate (salt), Ergotamane-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'-alpha,10-alpha)-, monomethanesulfonate (salt), GNF Pf 3462, Unii-Ds7Cl18Uam

Beschreibung

Dihydroergocristine is an anti-hypertensive drug that belongs to the class of pharmacological agents. It is used for the treatment of high blood pressure and has been shown to reduce the risk of stroke in patients with cerebrovascular disease. Dihydroergocristine has been found to inhibit the production of 5-hydroxytryptamine (5-HT) by binding to serotonin receptors in vitro, although its effects on human serum levels have not been determined. This drug also inhibits certain enzymes, such as energy metabolism and protein synthesis. Dihydroergocristine can be administered in a solution or as an injection, depending on the severity of symptoms.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 707.84 g/mol
• Formel: C₃₆H₄₅N₅O₈S
• Reinheit: Min. 95%
• Farbe/Form: Solid